ENGLEWOOD, Colo., Dec. 2 /PRNewswire/ -- Baxa Corporation is sponsoring a presentation discussing proposed changes to the sterile compounding requirements under USP Chapter 797. The Exhibitor's Theatre presentation, "What's Next With USP 797?" details the changes under discussion and their likely impact on pharmacy practice. The program provides pharmacy directors and managers with an overview of the new requirements and the reason for the changes, and includes a discussion of the steps that healthcare providers can take to influence the final revision. The program takes place on Monday, December 5, at the meeting of the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting at the Las Vegas Convention Center.
The presentation is expected to help pharmacy directors and operational managers better understand the requirements for meeting the environmental controls outlined for sterile compounding under the new Chapter. The program includes a discussion of current state for pharmacy compliance and the necessary next steps in moving from gap analysis to action plan for addressing the pharmacy changes to comply with USP 797.
The presenter, Eric Kastango, MBA, RPh, is a Fellow of the American Society of Health-System Pharmacists and has served on the ASHP's Council of Education Affairs and as a pharmacy surveyor for the Accreditation Commission for Health Care, Inc. (ACHC). Kastango travels across the United States to make professional presentations on a variety of pharmacy practice topics, including USP General Chapter <797> compliance, sterile preparation and pharmacy compounding errors, quality systems and collaborative pharmacy/nursing practice models. He is an elected member of the United States Pharmacopeia Council of Experts (Sterile Compounding Committee).
ASHP is a 30,000-member national organization representing pharmacists practicing in hospitals, homecare, HMOs and alternate-site facilities. The Society provides extensive published and educational resources that help pharmacists improve their professional standards and make the best use of medicines and technology for patient safety and improved outcomes. ASHP holds two annual meetings for members and industry representatives.
The complimentary educational program will be held Monday, December 5th in Exhibitor's Theatre 11, Room N262 of the Las Vegas Convention Center, beginning at 11:15 PM. Participants are eligible for one credit hour of Continuing Education (CEU).
About Baxa Corporation
Celebrating 30 years of business in 2005, Baxa Corporation is a Denver-based manufacturer of medical devices and systems for preparing, handling, packaging, and administering liquid medications. The company manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Privately held, Baxa Corporation has offices and subsidiaries in Canada, the United Kingdom and Denmark; and distribution partners worldwide. Further information is available at www.baxa.com.
Contact: Marian Robinson, Vice President, Marketing Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157 Email: marian.robinson@baxa.com Maggie Chamberlin Holben, APR Absolutely Public Relations: 303.984.9801 or 303.669.3558 Email: maggie@absolutelypr.com
Baxa CorporationCONTACT: Marian Robinson, Vice President, Marketing of Baxa Corporation,+1-800-567-2292, ext. 2157, or +1-303-617-2157, marian.robinson@baxa.com;or Maggie Chamberlin Holben, APR, Absolutely Public Relations,+1-303-984-9801, or +1-303-669-3558, maggie@absolutelypr.com, for BaxaCorporation
Web site: http://www.baxa.com/
